Azimzadeh, M.; Möhn, N.; Ghane Ezabadi, S.; Moghimi Esfandabadi, Z.; Soleimani, A.; Ranjbar, E.; Jahromi, M.; Seyedebrahimi, R.; Skripuletz, T.; Moharrami Kasmaie, F.
The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic. Biomolecules 2021, 11, 1372.
https://doi.org/10.3390/biom11091372
AMA Style
Azimzadeh M, Möhn N, Ghane Ezabadi S, Moghimi Esfandabadi Z, Soleimani A, Ranjbar E, Jahromi M, Seyedebrahimi R, Skripuletz T, Moharrami Kasmaie F.
The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic. Biomolecules. 2021; 11(9):1372.
https://doi.org/10.3390/biom11091372
Chicago/Turabian Style
Azimzadeh, Maryam, Nora Möhn, Sajjad Ghane Ezabadi, Zahra Moghimi Esfandabadi, Alireza Soleimani, Elaheh Ranjbar, Maliheh Jahromi, Reihaneh Seyedebrahimi, Thomas Skripuletz, and Farshad Moharrami Kasmaie.
2021. "The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic" Biomolecules 11, no. 9: 1372.
https://doi.org/10.3390/biom11091372
APA Style
Azimzadeh, M., Möhn, N., Ghane Ezabadi, S., Moghimi Esfandabadi, Z., Soleimani, A., Ranjbar, E., Jahromi, M., Seyedebrahimi, R., Skripuletz, T., & Moharrami Kasmaie, F.
(2021). The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic. Biomolecules, 11(9), 1372.
https://doi.org/10.3390/biom11091372
